Literature DB >> 3763928

Giant cell tumors of bone: treatment with radiation therapy.

M J Seider, T A Rich, A G Ayala, J A Murray.   

Abstract

Records of 15 patients with giant cell tumor of bone treated with radiation therapy over a 35-year period were reviewed; ten patients for whom follow-up information was available constituted the study group. One patient was treated by means of orthovoltage equipment only, a second, by both orthovoltage and megavoltage equipment (cobalt 60). The remaining eight were all treated with megavoltage to doses of 40-52 Gy in 24-30 fractions. Seven patients are alive without disease, with an average survival of 192 months (range, 48-360 months). Three patients died of uncontrolled local and distant disease (average survival, 52 months; range, 23-99 months): one with metastasis in the lungs at time of treatment and two after treatment. Although incidence of lung metastasis appears high, it may be due to patient selection because chemotherapy had failed in all three. Complications from irradiation in one surviving patient required surgical closure of a dural fistula 19 years after treatment. No radiation-induced sarcomatous transformations of controlled tumors were noted. These data suggest that giant cell tumor of bone can be well controlled by radiation therapy. Megavoltage irradiation should be considered in treating local disease not easily controlled by surgery in the axial skeleton. Complications are minimal, and normal function can be preserved in the treated areas.

Entities:  

Mesh:

Year:  1986        PMID: 3763928     DOI: 10.1148/radiology.161.2.3763928

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  14 in total

1.  Giant cell tumor of the rib with direct invasion into the thoracic spine.

Authors:  Ichiro Sakanoue; Hiroshi Hamakawa; Eijiro Onishi; Yukihiro Imai; Yutaka Takahashi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2016-05-12

2.  A giant cell tumor of the cranial base treated by stereotactic radiosurgery.

Authors:  Eun-Young Kim; Judith A Murovic; Iris C Gibbs; Lawrence M Shuer; Steven D Chang
Journal:  J Radiosurg SBRT       Date:  2012

3.  Aggressive clinical course of giant cell tumor arising from thoracic vertebra after a long latent period.

Authors:  Takeo Takahashi; Susumu Katano; Hitoshi Ishikawa; Takashi Nakano
Journal:  Radiat Med       Date:  2006-08

Review 4.  Therapeutic radiotherapy for giant cell tumor of the spine: a systemic review.

Authors:  Yifei Ma; Wei Xu; Huabin Yin; Quan Huang; Tielong Liu; Xinghai Yang; Haifeng Wei; Jianru Xiao
Journal:  Eur Spine J       Date:  2015-05-06       Impact factor: 3.134

5.  Intralesional excision versus wide resection for giant cell tumor involving the acetabulum: which is better?

Authors:  Wei Guo; Xin Sun; Jie Zang; Huayi Qu
Journal:  Clin Orthop Relat Res       Date:  2011-11-29       Impact factor: 4.176

Review 6.  Intensity modulated radiotherapy (IMRT) in benign giant cell tumors--a single institution case series and a short review of the literature.

Authors:  Falk Roeder; Carmen Timke; Felix Zwicker; Christian Thieke; Marc Bischof; Jürgen Debus; Peter E Huber
Journal:  Radiat Oncol       Date:  2010-02-26       Impact factor: 3.481

7.  Surgical resection and reconstruction for a giant cell tumor of the anterior rib.

Authors:  Akira Mogi; Takayuki Kosaka; Ei Yamaki; Junko Hirato; Hiroyuki Kuwano
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-03-28

8.  Giant cell tumor of the occipital bone: A case report and review of the literature.

Authors:  Gonca Hanedan Uslu; Emine Canyilmaz; Adnan Yöney; Sevdegül Aydin; Asli Sahbaz; Ahmet Sari
Journal:  Oncol Lett       Date:  2014-04-25       Impact factor: 2.967

9.  A locally invasive giant cell tumor of the skull base: case report.

Authors:  J T Billingsley; R M Wiet; G J Petruzzelli; R Byrne
Journal:  J Neurol Surg Rep       Date:  2014-06-24

10.  TRAIL-R1 as a novel surface marker for circulating giant cell tumor of bone.

Authors:  Jian-Xiang Liu; Zhi-Cai Zhang; Zeng-Wu Shao; Fei-Fei Pu; Bai-Chuan Wang; Yu-Kun Zhang; Xian-Lin Zeng; Xiao-Dong Guo; Shu-Hua Yang; Tong-Chuan He
Journal:  Oncotarget       Date:  2017-04-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.